Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ars Pharmaceuticals Inc (SPRY)

Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

SPRY : 15.32 (+0.79%)
3 Top 100 Stocks to Buy Moving Up 20 Spots or More

As investors might know, September is historically the worst month for stock returns. The S&P 500 has averaged a 5.8% decline in September in the past four years—these three Top 100 Stocks to Buy look...

RAIL : 12.46 (+0.97%)
SPRY : 15.32 (+0.79%)
GGAL : 51.79 (+0.08%)
Stocks Settle Higher on Favorable PPI Report

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +1.68%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.50%. US stocks settled...

$SPX : 5,782.76 (+1.23%)
SPY : 576.70 (+1.21%)
$DOWI : 42,221.88 (+1.02%)
DIA : 422.30 (+1.02%)
$IUXX : 20,227.46 (+1.32%)
QQQ : 492.21 (+1.28%)
ZNZ24 : 110-165 (+0.10%)
SBUX : 97.09 (+0.06%)
NVDA : 139.91 (+2.84%)
INTC : 23.32 (+3.55%)
ARM : 140.65 (+2.27%)
MRVL : 87.19 (+3.33%)
Stocks Rally on a Muted US July PPI Report

The S&P 500 Index ($SPX ) (SPY ) today is up +0.92%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.50%. US stocks today are moderately...

$SPX : 5,782.76 (+1.23%)
SPY : 576.70 (+1.21%)
$DOWI : 42,221.88 (+1.02%)
DIA : 422.30 (+1.02%)
$IUXX : 20,227.46 (+1.32%)
QQQ : 492.21 (+1.28%)
ZNZ24 : 110-165 (+0.10%)
SBUX : 97.09 (+0.06%)
NVDA : 139.91 (+2.84%)
INTC : 23.32 (+3.55%)
MRVL : 87.19 (+3.33%)
AMD : 141.66 (+0.68%)
Stocks Climb After US July PPI Rises Less Than Expected

The S&P 500 Index ($SPX ) (SPY ) today is up +0.80%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.14%. US stocks today are moving higher,...

$SPX : 5,782.76 (+1.23%)
SPY : 576.70 (+1.21%)
$DOWI : 42,221.88 (+1.02%)
DIA : 422.30 (+1.02%)
$IUXX : 20,227.46 (+1.32%)
QQQ : 492.21 (+1.28%)
ZNZ24 : 110-165 (+0.10%)
SBUX : 97.09 (+0.06%)
NVDA : 139.91 (+2.84%)
ARM : 140.65 (+2.27%)
MU : 105.49 (+3.70%)
AMD : 141.66 (+0.68%)
Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday

The company received a Complete Response Letter from the FDA regarding its lead therapy.

SPRY : 15.32 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 15.32 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 15.32 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 15.32 (+0.79%)

Barchart Exclusives

Valued at $3.43 Trillion, Is Nvidia Stock Really Undervalued?
SoftBank CEO Masayoshi Son has boldly claimed that Nvidia, already worth $3.4 trillion, is undervalued, citing the company's position at the heart of the artificial intelligence revolution. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar